XML 109 R85.htm IDEA: XBRL DOCUMENT
v3.25.2

Financial Instruments and Financial Risk Management - Schedule of Carrying Value of the Financial Instruments (Details) - USD ($) | Mar. 31, 2025 | Mar. 31, 2024
--- | --- | ---
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | $ 945,096 | $ 11,349,497
Investment in Psyence Labs Ltd [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | 745,000 |
NCAC Sponsor promissory note [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 1,474,256
Level 1 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | 200,096 | 875,000
Level 1 [Member] | Investment in Psyence Labs Ltd [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Level 1 [Member] | NCAC Sponsor promissory note [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Level 2 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | 745,000 | 26,608
Level 2 [Member] | Investment in Psyence Labs Ltd [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | 745,000 |
Level 2 [Member] | NCAC Sponsor promissory note [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Level 3 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 10,447,889
Level 3 [Member] | Investment in Psyence Labs Ltd [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Level 3 [Member] | NCAC Sponsor promissory note [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 1,474,256
Warrant Liabilities [Member] | Derivative warrant liabilities – public warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | 200,096 | 875,000
Warrant Liabilities [Member] | Derivative warrant liabilities – private warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 26,608
Warrant Liabilities [Member] | Level 1 [Member] | Derivative warrant liabilities – public warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value | 200,096 | 875,000
Warrant Liabilities [Member] | Level 1 [Member] | Derivative warrant liabilities – private warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Warrant Liabilities [Member] | Level 2 [Member] | Derivative warrant liabilities – public warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Warrant Liabilities [Member] | Level 2 [Member] | Derivative warrant liabilities – private warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 26,608
Warrant Liabilities [Member] | Level 3 [Member] | Derivative warrant liabilities – public warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Warrant Liabilities [Member] | Level 3 [Member] | Derivative warrant liabilities – private warrants [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Convertible notes [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 7,657,397
Convertible notes [Member] | Level 1 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Convertible notes [Member] | Level 2 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
Convertible notes [Member] | Level 3 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 7,657,397
PGI promissory note [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | 1,316,236
PGI promissory note [Member] | Level 1 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
PGI promissory note [Member] | Level 2 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  |
PGI promissory note [Member] | Level 3 [Member] |  |
Schedule of Carrying Value of the Financial Instruments [Line Items] |  |
Financial instruments at fair value |  | $ 1,316,236

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinancialLiabilitiesAtFairValue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=pbm_InvestmentInPsyenceLabsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=pbm_NcacSponsorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialLiabilitiesAxis=pbm_WarrantLiabilitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | pbm_IfrsClassOfWarrantOrRightAxis=pbm_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | pbm_IfrsClassOfWarrantOrRightAxis=pbm_PrivateWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialLiabilitiesAxis=pbm_IfrsConvertibleDebtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialLiabilitiesAxis=pbm_IfrsPromissoryNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |